nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisone—systemic scleroderma	0.331	1	CiPCiCtD
Fluticasone Propionate—Mometasone—systemic scleroderma	0.288	1	CrCtD
Fluticasone Propionate—NR3C1—Mometasone—systemic scleroderma	0.0615	0.641	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisone—systemic scleroderma	0.0196	0.204	CbGbCtD
Fluticasone Propionate—Fluticasone furoate—Mometasone—systemic scleroderma	0.00896	0.0402	CrCrCtD
Fluticasone Propionate—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.00877	0.0913	CbGbCtD
Fluticasone Propionate—Flumethasone Pivalate—Mometasone—systemic scleroderma	0.00805	0.0361	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Mometasone—systemic scleroderma	0.00779	0.035	CrCrCtD
Fluticasone Propionate—Difluprednate—Mometasone—systemic scleroderma	0.00779	0.035	CrCrCtD
Fluticasone Propionate—Clocortolone—Mometasone—systemic scleroderma	0.00732	0.0329	CrCrCtD
Fluticasone Propionate—Beclomethasone—Mometasone—systemic scleroderma	0.00732	0.0329	CrCrCtD
Fluticasone Propionate—Prednicarbate—Mometasone—systemic scleroderma	0.00732	0.0329	CrCrCtD
Fluticasone Propionate—Fluocinonide—Mometasone—systemic scleroderma	0.00732	0.0329	CrCrCtD
Fluticasone Propionate—Fluocortolone—Mometasone—systemic scleroderma	0.00711	0.0319	CrCrCtD
Fluticasone Propionate—Alclometasone—Mometasone—systemic scleroderma	0.00692	0.0311	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.00692	0.0311	CrCrCtD
Fluticasone Propionate—Amcinonide—Mometasone—systemic scleroderma	0.00673	0.0302	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Mometasone—systemic scleroderma	0.00656	0.0294	CrCrCtD
Fluticasone Propionate—Flunisolide—Mometasone—systemic scleroderma	0.00656	0.0294	CrCrCtD
Fluticasone Propionate—Diflorasone—Mometasone—systemic scleroderma	0.00656	0.0294	CrCrCtD
Fluticasone Propionate—Paramethasone—Mometasone—systemic scleroderma	0.00639	0.0287	CrCrCtD
Fluticasone Propionate—Desoximetasone—Mometasone—systemic scleroderma	0.00624	0.028	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.00609	0.0273	CrCrCtD
Fluticasone Propionate—Fluorometholone—Mometasone—systemic scleroderma	0.00609	0.0273	CrCrCtD
Fluticasone Propionate—Triamcinolone—Mometasone—systemic scleroderma	0.00609	0.0273	CrCrCtD
Fluticasone Propionate—Betamethasone—Mometasone—systemic scleroderma	0.00595	0.0267	CrCrCtD
Fluticasone Propionate—Rimexolone—Mometasone—systemic scleroderma	0.00595	0.0267	CrCrCtD
Fluticasone Propionate—Dexamethasone—Mometasone—systemic scleroderma	0.00595	0.0267	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Mometasone—systemic scleroderma	0.00569	0.0256	CrCrCtD
Fluticasone Propionate—Prednicarbate—Prednisone—systemic scleroderma	0.00399	0.0179	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisone—systemic scleroderma	0.00388	0.0174	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisone—systemic scleroderma	0.00377	0.0169	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisone—systemic scleroderma	0.00367	0.0165	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisone—systemic scleroderma	0.00357	0.016	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisone—systemic scleroderma	0.00357	0.016	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisone—systemic scleroderma	0.00357	0.016	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisone—systemic scleroderma	0.00349	0.0156	CrCrCtD
Fluticasone Propionate—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00342	0.0356	CbGbCtD
Fluticasone Propionate—Desoximetasone—Prednisone—systemic scleroderma	0.0034	0.0153	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisone—systemic scleroderma	0.00332	0.0149	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisone—systemic scleroderma	0.00332	0.0149	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00332	0.0149	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisone—systemic scleroderma	0.00332	0.0149	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisone—systemic scleroderma	0.00324	0.0146	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisone—systemic scleroderma	0.00324	0.0146	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisone—systemic scleroderma	0.00324	0.0146	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisone—systemic scleroderma	0.0031	0.0139	CrCrCtD
Fluticasone Propionate—CYP3A4—Prednisone—systemic scleroderma	0.00273	0.0285	CbGbCtD
Fluticasone Propionate—PLA2G4A—Enalapril—Captopril—systemic scleroderma	0.000543	0.469	CbGdCrCtD
Fluticasone Propionate—PGR—artery—systemic scleroderma	0.000396	0.125	CbGeAlD
Fluticasone Propionate—PGR—blood vessel—systemic scleroderma	0.000308	0.097	CbGeAlD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—systemic scleroderma	0.000301	0.259	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—connective tissue—systemic scleroderma	0.000209	0.0658	CbGeAlD
Fluticasone Propionate—PLA2G4A—smooth muscle tissue—systemic scleroderma	0.000191	0.0602	CbGeAlD
Fluticasone Propionate—PLA2G4A—Enalapril—Lisinopril—systemic scleroderma	0.000179	0.155	CbGdCrCtD
Fluticasone Propionate—NR3C2—connective tissue—systemic scleroderma	0.00017	0.0535	CbGeAlD
Fluticasone Propionate—PGR—connective tissue—systemic scleroderma	0.000158	0.0497	CbGeAlD
Fluticasone Propionate—NR3C2—smooth muscle tissue—systemic scleroderma	0.000156	0.0489	CbGeAlD
Fluticasone Propionate—PGR—smooth muscle tissue—systemic scleroderma	0.000145	0.0455	CbGeAlD
Fluticasone Propionate—PLA2G4A—tendon—systemic scleroderma	0.000144	0.0452	CbGeAlD
Fluticasone Propionate—PLA2G4A—lung—systemic scleroderma	0.000126	0.0397	CbGeAlD
Fluticasone Propionate—SERPINA6—lung—systemic scleroderma	0.000126	0.0395	CbGeAlD
Fluticasone Propionate—NR3C2—digestive system—systemic scleroderma	0.000123	0.0386	CbGeAlD
Fluticasone Propionate—NR3C2—tendon—systemic scleroderma	0.000117	0.0368	CbGeAlD
Fluticasone Propionate—NR3C2—lung—systemic scleroderma	0.000103	0.0323	CbGeAlD
Fluticasone Propionate—PGR—lung—systemic scleroderma	9.53e-05	0.03	CbGeAlD
Fluticasone Propionate—NR3C1—connective tissue—systemic scleroderma	9.12e-05	0.0287	CbGeAlD
Fluticasone Propionate—NR3C1—smooth muscle tissue—systemic scleroderma	8.34e-05	0.0263	CbGeAlD
Fluticasone Propionate—NR3C1—skin of body—systemic scleroderma	8.24e-05	0.0259	CbGeAlD
Fluticasone Propionate—CYP3A5—digestive system—systemic scleroderma	6.64e-05	0.0209	CbGeAlD
Fluticasone Propionate—NR3C1—digestive system—systemic scleroderma	6.59e-05	0.0207	CbGeAlD
Fluticasone Propionate—NR3C1—tendon—systemic scleroderma	6.27e-05	0.0197	CbGeAlD
Fluticasone Propionate—CYP3A5—lung—systemic scleroderma	5.54e-05	0.0174	CbGeAlD
Fluticasone Propionate—NR3C1—lung—systemic scleroderma	5.5e-05	0.0173	CbGeAlD
Fluticasone Propionate—CYP3A4—digestive system—systemic scleroderma	4.98e-05	0.0157	CbGeAlD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Mometasone—systemic scleroderma	4.4e-05	0.0379	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Mometasone—systemic scleroderma	4.4e-05	0.0379	CbGdCrCtD
Fluticasone Propionate—Face oedema—Prednisone—systemic scleroderma	4.33e-05	0.000746	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Leflunomide—systemic scleroderma	4.32e-05	0.000745	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Captopril—systemic scleroderma	4.32e-05	0.000745	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Methotrexate—systemic scleroderma	4.31e-05	0.000743	CcSEcCtD
Fluticasone Propionate—Arthralgia—Mycophenolic acid—systemic scleroderma	4.3e-05	0.000741	CcSEcCtD
Fluticasone Propionate—Chest pain—Mycophenolic acid—systemic scleroderma	4.3e-05	0.000741	CcSEcCtD
Fluticasone Propionate—Infection—Leflunomide—systemic scleroderma	4.29e-05	0.00074	CcSEcCtD
Fluticasone Propionate—Vision blurred—Lisinopril—systemic scleroderma	4.29e-05	0.000739	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Captopril—systemic scleroderma	4.29e-05	0.000739	CcSEcCtD
Fluticasone Propionate—Anxiety—Mycophenolic acid—systemic scleroderma	4.29e-05	0.000738	CcSEcCtD
Fluticasone Propionate—Irritability—Prednisone—systemic scleroderma	4.28e-05	0.000738	CcSEcCtD
Fluticasone Propionate—Eye disorder—Mycophenolate mofetil—systemic scleroderma	4.28e-05	0.000737	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	4.27e-05	0.000736	CcSEcCtD
Fluticasone Propionate—Tremor—Lisinopril—systemic scleroderma	4.26e-05	0.000735	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	4.25e-05	0.000732	CcSEcCtD
Fluticasone Propionate—Discomfort—Mycophenolic acid—systemic scleroderma	4.25e-05	0.000732	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Leflunomide—systemic scleroderma	4.24e-05	0.00073	CcSEcCtD
Fluticasone Propionate—Pruritus—Mometasone—systemic scleroderma	4.22e-05	0.000728	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Lisinopril—systemic scleroderma	4.22e-05	0.000727	CcSEcCtD
Fluticasone Propionate—Tachycardia—Leflunomide—systemic scleroderma	4.22e-05	0.000727	CcSEcCtD
Fluticasone Propionate—Dry mouth—Mycophenolic acid—systemic scleroderma	4.21e-05	0.000725	CcSEcCtD
Fluticasone Propionate—Skin disorder—Leflunomide—systemic scleroderma	4.2e-05	0.000723	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	4.17e-05	0.000718	CcSEcCtD
Fluticasone Propionate—Angioedema—Lisinopril—systemic scleroderma	4.16e-05	0.000716	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Captopril—systemic scleroderma	4.15e-05	0.000714	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Captopril—systemic scleroderma	4.15e-05	0.000714	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	4.13e-05	0.000711	CcSEcCtD
Fluticasone Propionate—Oedema—Mycophenolic acid—systemic scleroderma	4.12e-05	0.00071	CcSEcCtD
Fluticasone Propionate—Nausea—Pentoxifylline—systemic scleroderma	4.11e-05	0.000708	CcSEcCtD
Fluticasone Propionate—Malaise—Lisinopril—systemic scleroderma	4.1e-05	0.000707	CcSEcCtD
Fluticasone Propionate—Infection—Mycophenolic acid—systemic scleroderma	4.1e-05	0.000706	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	4.09e-05	0.000705	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mometasone—systemic scleroderma	4.09e-05	0.000704	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Mycophenolic acid—systemic scleroderma	4.04e-05	0.000697	CcSEcCtD
Fluticasone Propionate—Tachycardia—Mycophenolic acid—systemic scleroderma	4.02e-05	0.000693	CcSEcCtD
Fluticasone Propionate—Palpitations—Lisinopril—systemic scleroderma	4.02e-05	0.000693	CcSEcCtD
Fluticasone Propionate—Mental disorder—Mycophenolate mofetil—systemic scleroderma	4.01e-05	0.000691	CcSEcCtD
Fluticasone Propionate—Skin disorder—Mycophenolic acid—systemic scleroderma	4.01e-05	0.00069	CcSEcCtD
Fluticasone Propionate—Malnutrition—Mycophenolate mofetil—systemic scleroderma	3.99e-05	0.000687	CcSEcCtD
Fluticasone Propionate—Cough—Lisinopril—systemic scleroderma	3.97e-05	0.000684	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	3.94e-05	0.000678	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Prednisone—systemic scleroderma	3.91e-05	0.000673	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Methotrexate—systemic scleroderma	3.88e-05	0.000668	CcSEcCtD
Fluticasone Propionate—Chest pain—Lisinopril—systemic scleroderma	3.87e-05	0.000667	CcSEcCtD
Fluticasone Propionate—Arthralgia—Lisinopril—systemic scleroderma	3.87e-05	0.000667	CcSEcCtD
Fluticasone Propionate—Anxiety—Lisinopril—systemic scleroderma	3.86e-05	0.000665	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Leflunomide—systemic scleroderma	3.85e-05	0.000664	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	3.85e-05	0.000663	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	3.83e-05	0.00066	CcSEcCtD
Fluticasone Propionate—Discomfort—Lisinopril—systemic scleroderma	3.83e-05	0.000659	CcSEcCtD
Fluticasone Propionate—Vomiting—Mometasone—systemic scleroderma	3.8e-05	0.000654	CcSEcCtD
Fluticasone Propionate—Dry mouth—Lisinopril—systemic scleroderma	3.79e-05	0.000653	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Azathioprine—systemic scleroderma	3.77e-05	0.00065	CcSEcCtD
Fluticasone Propionate—Rash—Mometasone—systemic scleroderma	3.77e-05	0.000649	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mometasone—systemic scleroderma	3.76e-05	0.000648	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	3.76e-05	0.000647	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Azathioprine—systemic scleroderma	3.74e-05	0.000645	CcSEcCtD
Fluticasone Propionate—Headache—Mometasone—systemic scleroderma	3.74e-05	0.000644	CcSEcCtD
Fluticasone Propionate—Tremor—Mycophenolate mofetil—systemic scleroderma	3.74e-05	0.000644	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Lisinopril—systemic scleroderma	3.71e-05	0.00064	CcSEcCtD
Fluticasone Propionate—Oedema—Lisinopril—systemic scleroderma	3.71e-05	0.00064	CcSEcCtD
Fluticasone Propionate—Pruritus—Captopril—systemic scleroderma	3.71e-05	0.000639	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	3.7e-05	0.000637	CcSEcCtD
Fluticasone Propionate—Pain—Leflunomide—systemic scleroderma	3.7e-05	0.000637	CcSEcCtD
Fluticasone Propionate—Infection—Lisinopril—systemic scleroderma	3.69e-05	0.000636	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Mycophenolic acid—systemic scleroderma	3.68e-05	0.000633	CcSEcCtD
Fluticasone Propionate—Agitation—Mycophenolate mofetil—systemic scleroderma	3.66e-05	0.000631	CcSEcCtD
Fluticasone Propionate—Angioedema—Mycophenolate mofetil—systemic scleroderma	3.64e-05	0.000628	CcSEcCtD
Fluticasone Propionate—Tachycardia—Lisinopril—systemic scleroderma	3.63e-05	0.000624	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Azathioprine—systemic scleroderma	3.62e-05	0.000623	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Azathioprine—systemic scleroderma	3.62e-05	0.000623	CcSEcCtD
Fluticasone Propionate—Skin disorder—Lisinopril—systemic scleroderma	3.61e-05	0.000621	CcSEcCtD
Fluticasone Propionate—Malaise—Mycophenolate mofetil—systemic scleroderma	3.6e-05	0.000619	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Captopril—systemic scleroderma	3.59e-05	0.000618	CcSEcCtD
Fluticasone Propionate—Irritability—Methotrexate—systemic scleroderma	3.58e-05	0.000617	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Leflunomide—systemic scleroderma	3.56e-05	0.000614	CcSEcCtD
Fluticasone Propionate—Nausea—Mometasone—systemic scleroderma	3.55e-05	0.000611	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Leflunomide—systemic scleroderma	3.53e-05	0.000609	CcSEcCtD
Fluticasone Propionate—Pain—Mycophenolic acid—systemic scleroderma	3.53e-05	0.000607	CcSEcCtD
Fluticasone Propionate—Palpitations—Mycophenolate mofetil—systemic scleroderma	3.52e-05	0.000607	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Prednisone—systemic scleroderma	3.5e-05	0.000603	CcSEcCtD
Fluticasone Propionate—Cough—Mycophenolate mofetil—systemic scleroderma	3.48e-05	0.000599	CcSEcCtD
Fluticasone Propionate—Dizziness—Captopril—systemic scleroderma	3.47e-05	0.000597	CcSEcCtD
Fluticasone Propionate—Hypertension—Mycophenolate mofetil—systemic scleroderma	3.44e-05	0.000593	CcSEcCtD
Fluticasone Propionate—Urticaria—Leflunomide—systemic scleroderma	3.43e-05	0.000592	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Leflunomide—systemic scleroderma	3.42e-05	0.000589	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Leflunomide—systemic scleroderma	3.42e-05	0.000589	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	3.4e-05	0.000585	CcSEcCtD
Fluticasone Propionate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	3.39e-05	0.000585	CcSEcCtD
Fluticasone Propionate—Chest pain—Mycophenolate mofetil—systemic scleroderma	3.39e-05	0.000585	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	3.38e-05	0.000583	CcSEcCtD
Fluticasone Propionate—Anxiety—Mycophenolate mofetil—systemic scleroderma	3.38e-05	0.000583	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Azathioprine—systemic scleroderma	3.37e-05	0.000581	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	3.37e-05	0.000581	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	3.37e-05	0.000581	CcSEcCtD
Fluticasone Propionate—Discomfort—Mycophenolate mofetil—systemic scleroderma	3.35e-05	0.000578	CcSEcCtD
Fluticasone Propionate—Vomiting—Captopril—systemic scleroderma	3.33e-05	0.000574	CcSEcCtD
Fluticasone Propionate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	3.32e-05	0.000572	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Lisinopril—systemic scleroderma	3.31e-05	0.00057	CcSEcCtD
Fluticasone Propionate—Rash—Captopril—systemic scleroderma	3.31e-05	0.00057	CcSEcCtD
Fluticasone Propionate—Dermatitis—Captopril—systemic scleroderma	3.3e-05	0.000569	CcSEcCtD
Fluticasone Propionate—Headache—Captopril—systemic scleroderma	3.29e-05	0.000566	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Mycophenolic acid—systemic scleroderma	3.26e-05	0.000562	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Mycophenolic acid—systemic scleroderma	3.26e-05	0.000562	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	3.25e-05	0.000561	CcSEcCtD
Fluticasone Propionate—Oedema—Mycophenolate mofetil—systemic scleroderma	3.25e-05	0.000561	CcSEcCtD
Fluticasone Propionate—Asthma—Methotrexate—systemic scleroderma	3.24e-05	0.000558	CcSEcCtD
Fluticasone Propionate—Infection—Mycophenolate mofetil—systemic scleroderma	3.23e-05	0.000557	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	3.19e-05	0.00055	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Leflunomide—systemic scleroderma	3.18e-05	0.000549	CcSEcCtD
Fluticasone Propionate—Pain—Lisinopril—systemic scleroderma	3.18e-05	0.000547	CcSEcCtD
Fluticasone Propionate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	3.18e-05	0.000547	CcSEcCtD
Fluticasone Propionate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	3.16e-05	0.000545	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Azathioprine—systemic scleroderma	3.13e-05	0.000539	CcSEcCtD
Fluticasone Propionate—Nausea—Captopril—systemic scleroderma	3.12e-05	0.000537	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—systemic scleroderma	3.11e-05	0.000535	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Lisinopril—systemic scleroderma	3.06e-05	0.000527	CcSEcCtD
Fluticasone Propionate—Pruritus—Leflunomide—systemic scleroderma	3.06e-05	0.000527	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Prednisone—systemic scleroderma	3.05e-05	0.000526	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Lisinopril—systemic scleroderma	3.04e-05	0.000523	CcSEcCtD
Fluticasone Propionate—Dizziness—Azathioprine—systemic scleroderma	3.03e-05	0.000521	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	3.01e-05	0.000519	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	2.97e-05	0.000511	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Leflunomide—systemic scleroderma	2.96e-05	0.000509	CcSEcCtD
Fluticasone Propionate—Urticaria—Lisinopril—systemic scleroderma	2.95e-05	0.000508	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Lisinopril—systemic scleroderma	2.94e-05	0.000506	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Lisinopril—systemic scleroderma	2.94e-05	0.000506	CcSEcCtD
Fluticasone Propionate—Pruritus—Mycophenolic acid—systemic scleroderma	2.92e-05	0.000503	CcSEcCtD
Fluticasone Propionate—Vomiting—Azathioprine—systemic scleroderma	2.91e-05	0.000501	CcSEcCtD
Fluticasone Propionate—Pneumonia—Methotrexate—systemic scleroderma	2.91e-05	0.000501	CcSEcCtD
Fluticasone Propionate—Eye disorder—Prednisone—systemic scleroderma	2.9e-05	0.0005	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	2.9e-05	0.0005	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Methotrexate—systemic scleroderma	2.89e-05	0.000498	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—systemic scleroderma	2.89e-05	0.000498	CcSEcCtD
Fluticasone Propionate—Rash—Azathioprine—systemic scleroderma	2.89e-05	0.000497	CcSEcCtD
Fluticasone Propionate—Dermatitis—Azathioprine—systemic scleroderma	2.88e-05	0.000497	CcSEcCtD
Fluticasone Propionate—Headache—Azathioprine—systemic scleroderma	2.87e-05	0.000494	CcSEcCtD
Fluticasone Propionate—Dizziness—Leflunomide—systemic scleroderma	2.86e-05	0.000492	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mycophenolic acid—systemic scleroderma	2.82e-05	0.000486	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Methotrexate—systemic scleroderma	2.81e-05	0.000484	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Prednisone—systemic scleroderma	2.8e-05	0.000483	CcSEcCtD
Fluticasone Propionate—Pain—Mycophenolate mofetil—systemic scleroderma	2.78e-05	0.000479	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Prednisone—systemic scleroderma	2.77e-05	0.000478	CcSEcCtD
Fluticasone Propionate—Vomiting—Leflunomide—systemic scleroderma	2.75e-05	0.000473	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Lisinopril—systemic scleroderma	2.74e-05	0.000471	CcSEcCtD
Fluticasone Propionate—Dizziness—Mycophenolic acid—systemic scleroderma	2.73e-05	0.00047	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—systemic scleroderma	2.73e-05	0.00047	CcSEcCtD
Fluticasone Propionate—Rash—Leflunomide—systemic scleroderma	2.73e-05	0.00047	CcSEcCtD
Fluticasone Propionate—Dermatitis—Leflunomide—systemic scleroderma	2.72e-05	0.000469	CcSEcCtD
Fluticasone Propionate—Mental disorder—Prednisone—systemic scleroderma	2.72e-05	0.000469	CcSEcCtD
Fluticasone Propionate—Nausea—Azathioprine—systemic scleroderma	2.72e-05	0.000468	CcSEcCtD
Fluticasone Propionate—Headache—Leflunomide—systemic scleroderma	2.71e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Malnutrition—Prednisone—systemic scleroderma	2.7e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Erythema—Prednisone—systemic scleroderma	2.7e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	2.68e-05	0.000462	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	2.66e-05	0.000458	CcSEcCtD
Fluticasone Propionate—Pruritus—Lisinopril—systemic scleroderma	2.63e-05	0.000453	CcSEcCtD
Fluticasone Propionate—Vomiting—Mycophenolic acid—systemic scleroderma	2.62e-05	0.000452	CcSEcCtD
Fluticasone Propionate—Rash—Mycophenolic acid—systemic scleroderma	2.6e-05	0.000448	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mycophenolic acid—systemic scleroderma	2.6e-05	0.000447	CcSEcCtD
Fluticasone Propionate—Urticaria—Mycophenolate mofetil—systemic scleroderma	2.59e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Headache—Mycophenolic acid—systemic scleroderma	2.58e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—systemic scleroderma	2.58e-05	0.000444	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	2.57e-05	0.000443	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	2.57e-05	0.000443	CcSEcCtD
Fluticasone Propionate—Nausea—Leflunomide—systemic scleroderma	2.57e-05	0.000442	CcSEcCtD
Fluticasone Propionate—Vision blurred—Prednisone—systemic scleroderma	2.55e-05	0.000439	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Lisinopril—systemic scleroderma	2.54e-05	0.000438	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Prednisone—systemic scleroderma	2.51e-05	0.000432	CcSEcCtD
Fluticasone Propionate—Agitation—Prednisone—systemic scleroderma	2.48e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Angioedema—Prednisone—systemic scleroderma	2.47e-05	0.000425	CcSEcCtD
Fluticasone Propionate—Dizziness—Lisinopril—systemic scleroderma	2.46e-05	0.000423	CcSEcCtD
Fluticasone Propionate—Nausea—Mycophenolic acid—systemic scleroderma	2.45e-05	0.000422	CcSEcCtD
Fluticasone Propionate—Malaise—Prednisone—systemic scleroderma	2.44e-05	0.00042	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—systemic scleroderma	2.43e-05	0.000418	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—systemic scleroderma	2.41e-05	0.000415	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisone—systemic scleroderma	2.4e-05	0.0207	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisone—systemic scleroderma	2.4e-05	0.0207	CbGdCrCtD
Fluticasone Propionate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	2.4e-05	0.000413	CcSEcCtD
Fluticasone Propionate—Vomiting—Lisinopril—systemic scleroderma	2.36e-05	0.000407	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—systemic scleroderma	2.34e-05	0.000404	CcSEcCtD
Fluticasone Propionate—Rash—Lisinopril—systemic scleroderma	2.34e-05	0.000403	CcSEcCtD
Fluticasone Propionate—Dermatitis—Lisinopril—systemic scleroderma	2.34e-05	0.000403	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—systemic scleroderma	2.34e-05	0.000403	CcSEcCtD
Fluticasone Propionate—Hypertension—Prednisone—systemic scleroderma	2.33e-05	0.000402	CcSEcCtD
Fluticasone Propionate—Headache—Lisinopril—systemic scleroderma	2.33e-05	0.000401	CcSEcCtD
Fluticasone Propionate—Pruritus—Mycophenolate mofetil—systemic scleroderma	2.3e-05	0.000397	CcSEcCtD
Fluticasone Propionate—Arthralgia—Prednisone—systemic scleroderma	2.3e-05	0.000396	CcSEcCtD
Fluticasone Propionate—Anxiety—Prednisone—systemic scleroderma	2.29e-05	0.000395	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	2.29e-05	0.000394	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisone—systemic scleroderma	2.27e-05	0.000392	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methotrexate—systemic scleroderma	2.27e-05	0.000392	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—systemic scleroderma	2.26e-05	0.000389	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—systemic scleroderma	2.26e-05	0.000389	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	2.23e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Nausea—Lisinopril—systemic scleroderma	2.21e-05	0.00038	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisone—systemic scleroderma	2.21e-05	0.00038	CcSEcCtD
Fluticasone Propionate—Oedema—Prednisone—systemic scleroderma	2.21e-05	0.00038	CcSEcCtD
Fluticasone Propionate—Infection—Prednisone—systemic scleroderma	2.19e-05	0.000378	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Prednisone—systemic scleroderma	2.16e-05	0.000373	CcSEcCtD
Fluticasone Propionate—Tachycardia—Prednisone—systemic scleroderma	2.15e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Dizziness—Mycophenolate mofetil—systemic scleroderma	2.15e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Skin disorder—Prednisone—systemic scleroderma	2.14e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—systemic scleroderma	2.13e-05	0.000367	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—systemic scleroderma	2.1e-05	0.000361	CcSEcCtD
Fluticasone Propionate—Vomiting—Mycophenolate mofetil—systemic scleroderma	2.07e-05	0.000356	CcSEcCtD
Fluticasone Propionate—Rash—Mycophenolate mofetil—systemic scleroderma	2.05e-05	0.000353	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	2.05e-05	0.000353	CcSEcCtD
Fluticasone Propionate—Headache—Mycophenolate mofetil—systemic scleroderma	2.04e-05	0.000351	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—systemic scleroderma	2.04e-05	0.000351	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	2.01e-05	0.000346	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—systemic scleroderma	1.97e-05	0.00034	CcSEcCtD
Fluticasone Propionate—Nausea—Mycophenolate mofetil—systemic scleroderma	1.93e-05	0.000333	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—systemic scleroderma	1.92e-05	0.000331	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—systemic scleroderma	1.92e-05	0.000331	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	1.91e-05	0.000329	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—systemic scleroderma	1.9e-05	0.000327	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—systemic scleroderma	1.84e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—systemic scleroderma	1.83e-05	0.000316	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Prednisone—systemic scleroderma	1.82e-05	0.000313	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—systemic scleroderma	1.81e-05	0.000311	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Prednisone—systemic scleroderma	1.8e-05	0.000311	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—systemic scleroderma	1.79e-05	0.000308	CcSEcCtD
Fluticasone Propionate—Urticaria—Prednisone—systemic scleroderma	1.75e-05	0.000302	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Prednisone—systemic scleroderma	1.74e-05	0.0003	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Prednisone—systemic scleroderma	1.74e-05	0.0003	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	1.68e-05	0.000289	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—systemic scleroderma	1.64e-05	0.000283	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Prednisone—systemic scleroderma	1.63e-05	0.00028	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—systemic scleroderma	1.58e-05	0.000272	CcSEcCtD
Fluticasone Propionate—Pruritus—Prednisone—systemic scleroderma	1.56e-05	0.000269	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—systemic scleroderma	1.52e-05	0.000262	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Prednisone—systemic scleroderma	1.51e-05	0.00026	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—systemic scleroderma	1.51e-05	0.00026	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—systemic scleroderma	1.46e-05	0.000252	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisone—systemic scleroderma	1.46e-05	0.000251	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—systemic scleroderma	1.46e-05	0.000251	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—systemic scleroderma	1.46e-05	0.000251	CcSEcCtD
Fluticasone Propionate—Vomiting—Prednisone—systemic scleroderma	1.4e-05	0.000242	CcSEcCtD
Fluticasone Propionate—Rash—Prednisone—systemic scleroderma	1.39e-05	0.00024	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisone—systemic scleroderma	1.39e-05	0.000239	CcSEcCtD
Fluticasone Propionate—Headache—Prednisone—systemic scleroderma	1.38e-05	0.000238	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methotrexate—systemic scleroderma	1.36e-05	0.000234	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisone—systemic scleroderma	1.31e-05	0.000226	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—systemic scleroderma	1.3e-05	0.000225	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—systemic scleroderma	1.26e-05	0.000217	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—systemic scleroderma	1.22e-05	0.00021	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—systemic scleroderma	1.17e-05	0.000202	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—systemic scleroderma	1.16e-05	0.0002	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—systemic scleroderma	1.16e-05	0.0002	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—systemic scleroderma	1.15e-05	0.000199	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—systemic scleroderma	1.1e-05	0.000189	CcSEcCtD
